Compugen Ltd.

Foreign Filer Report • Jun 22, 2023

�������'� ������ �� ����� ����� ������ ����� ������ ������� �� ����� ����� �� COM701, COM902 �- Pembrolizumab ����� ����� ���� ������� ������� false

�������� ��"�	2 380
COMPUGEN LTD
Corporation no: 511779639	12833
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	22/06/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-068580	Time of broadcast: 10:12 10:12

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on�������'� ������ �� ����� ����� ������ ����� ������ ������� �� ����� ����� �� COM701, COM902 �- Pembrolizumab ����� ����� ���� ������� �������

a2329904_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: TASE	Date of revision of form structure: 20/06/2023
Address: Harokmim 26 , Holon 5885849   , Israel Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
E-mail address: donnag@cgen.com
Previous names of reporting entity:
Name of the Signatory: Ben Dor Eran Position of Signatory in the reporting corporation: General Counsel & Corporate Secretary Name of Employer Company:
Address: Harokmim 26 , Holon 5885849 Telephone: 03-7658585 Facsimile: 03-7658555 E-mail: eranbd@cgen.com 1
Israel